Inventor · disambiguated record
Chester Bittencort Sacramento
Also filed as: SACRAMENTO CHESTER · SACRAMENTO CHESTER BITTENCORT
1 granted patent·10 pending applications·1 citations·filing 2021–2023
17Inventor score
Top patents by PatentIndex Score
11 records- 0176US11883506B2Plakophilin-2 (PKP2) gene therapy using AAV vectorSPACECRAFT SEVEN LLC·Filed 2022·Granted Jan 30, 2024·1 cites·12 claims
- 0267US2024408233A1Plakophilin-2 (pkp2) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2023·Application pending·0 cites
- 0367US2024390519A1Plakophilin-2 (pkp2) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2023·Application pending·0 cites
- 0453US2025269065A1B-cell lymphoma 2-associated anthanogene 3 (bag3) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2023·Application pending·0 cites
- 0551US2025135040A1Adeno-associated viral vector for glut1 expression and uses thereofSPACECRAFT SEVEN LLC·Filed 2023·Application pending·0 cites
- 0651US2024335566A1Troponin c (tnnc1) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2022·Application pending·0 cites
- 0751US2024335565A1Junctophilin-2 (jph2) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2022·Application pending·0 cites
- 0849US2023330265A1GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOFUCL BUSINESS LTD·Filed 2021·Application pending·0 cites
- 0945US2023272422A1Adeno-associated viral vector for glut1 expression and uses thereofSPACECRAFT SEVEN LLC·Filed 2021·Application pending·0 cites
- 1041US2023257431A1Csrp3 (cysteine and glycine rich protein 3) gene therapySPACECRAFT SEVEN LLC·Filed 2021·Application pending·0 cites
- 1140US2023174994A1Engineered parkin and uses thereofSPACECRAFT SEVEN LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chester Bittencort Sacramento files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →